US Prioritizes AI Integration in Asia Following TrumpXi Engagement Gold Rally May Depend on Renewed Fed Rate Cut Expectations The Power of Acting As If Financial Lessons from Theatre and Music Stars Consumer Sentiment Drops to Fresh Record Low in May on Iran Conflict and Oil Price Concerns Lidl Surpasses Morrisons to Claim FifthLargest Grocery Spot in Great Britain Wall Street Rises as Tech Stocks Rally and USIran Talks Progress Theravance Biopharma Inc TBPH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise RILYP Q1 2024 Earnings Preferred Shares Report Negative EPS Amid No Revenue or Estimate WKHS Q1 2026 Earnings Deeper Losses on Zero Revenue Highlight EV Startups Cash Challenges REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss Alight Inc Q1 2026 Earnings EPS Surprise Beats Estimates Stock Edges Higher SFNC Q1 2026 Earnings Slight EPS Miss Amid Stable Operations Titan Acquisition Corp Units TACHU Hold Steady at 1045 as Trading Activity Remains Muted Natural Health Trends NHTC Edges Lower as Stock Hovers Between Key Support and Resistance Levels CoreCivic Inc CXW Edges Lower Testing Key Support Levels Amid Modest Decline ABVC BioPharma Consolidates at 139 as Support and Resistance Levels Narrow T3 Defense Inc DFNS Surges Over 18 as Defense Sector Momentum Builds Barclays Profit Climbs 18 on Strong Banking Income Raises FullYear Guidance Seacoast Banking Corporation of Florida SBCF Q1 2026 Earnings Modest EPS Beat Offsets Flat Revenue Trends CRAQ Stock Holds Steady at 1026 as Support and Resistance Levels Define Range Cannae Holdings Q1 2026 Earnings Wide EPS Miss as Investment Losses Bite Modular Medical Inc MODD Q3 2025 Earnings EPS Miss Weighs Despite Positive Stock Reaction LeonaBio Inc LONA Q1 2026 Earnings EPS Surprise Provides Bright Spot Amid Revenue Absence and Stock Decline REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4 MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates as Earnings Surprise Exceeds 5 FBLG Q1 2026 Earnings PreRevenue Biotech Posts Slight EPS Miss No Revenue Reported ROP Q1 2026 Earnings EPS Beat Driven by Operational Strength Amid Modest Market Response